One Drop Experts Program for Type 2 Diabetes Self-Management: Impact on A1c
Status: | Active, not recruiting |
---|---|
Conditions: | Diabetes, Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - 75 |
Updated: | 2/8/2017 |
Start Date: | June 2016 |
The One Drop Experts Program for Type 2 Diabetes Self-Management Impact on A1c trial is a
12-week long, prospective, intent-to-treat study that aims to evaluate the impact of the One
Drop app and Experts program on HbA1c levels for individuals with uncontrolled Type 2
diabetes. A secondary objective will be to evaluate participants who utilize an Apple Watch
in combination with the One Drop app and Experts program, and assess whether this group is
more engaged or experiences a different impact as compared to participants who utilized the
One Drop app and Experts program only.
12-week long, prospective, intent-to-treat study that aims to evaluate the impact of the One
Drop app and Experts program on HbA1c levels for individuals with uncontrolled Type 2
diabetes. A secondary objective will be to evaluate participants who utilize an Apple Watch
in combination with the One Drop app and Experts program, and assess whether this group is
more engaged or experiences a different impact as compared to participants who utilized the
One Drop app and Experts program only.
Inclusion Criteria:
- Self-reported Type 2 diabetes diagnosis
- Has not changed treatment regimen in the last 3 months
- HbA1c levels ≥ 7.5% by self-report and verified by lab test
- Motivated to use a daily diabetes self-management coaching program to improve
diabetes control
- Owns and uses an iPhone with a compatible iOS operating system and has successfully
downloaded and used a smartphone application previously
Exclusion Criteria:
- Current use of a smartphone application to manage their diabetes
- Currently participating in a diabetes self-management education or coaching program
- Currently pregnant
- Does not understand English
- History of serious mental illness or dementia
- Has severe diabetic complications such as severe diabetic retinopathy, chronic kidney
disease (stages 4-5), severe diabetic neuropathy, diabetic foot ulcer or infection
We found this trial at
1
site
Click here to add this to my saved trials
